Skip to content

Penn Biobank Return of Research Results Program

A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04242667
Enrollment
260
Registered
2020-01-27
Start date
2020-03-01
Completion date
2023-08-01
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cardiovascular Diseases, Hereditary Cancer, Hereditary Cardiac Amyloidosis

Brief summary

The overall goal of the proposed research is to assess the feasibility of a randomized study evaluating the non-inferiority of an electronic Health (e-Health) delivery alternative (e.g. private web portal) as compared to return of actionable genetic research results with a genetic counselor.

Interventions

BEHAVIORALe-Health (web-based) disclosure portal

Patient uses secure web-based portal to access genetic research results

BEHAVIORALProvider mediated disclosure

Patient has disclosure of genetic research result by a provider (genetic counselor)

Sponsors

Fox Chase Cancer Center
CollaboratorOTHER
Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Consented participant in University of Pennsylvania Biobank who previously submitted a DNA sample for research testing 2. English speaking 3. Aged 18 years or older 4. Agreed to be re-contacted in the future or did not indicate a preference on future contact regarding research results 5. Have an actionable mutation or have been selected as a control participant 6. Have not previously received actionable results of clinical genetic testing

Exclusion criteria

1. Deceased assessed by electronic medical record, death index or identified after contact 2. Evidence in the electronic medical record that the subject has already received the same actionable result through clinical genetic testing

Design outcomes

Primary

MeasureTime frameDescription
Completion of surveysBaseline survey prior to disclosure of results, and then two post-disclosure surveys at 2-7 days and 6 monthsParticipant will self-complete surveys to collect psychological and knowledge outcomes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026